ARTICLE
31 August 2020

Bayer Pays $10B+ To Settle Roundup Cancer Suits

CC
Clyde & Co

Contributor

Clyde & Co  logo
Clyde & Co is a leading, sector-focused global law firm with 415 partners, 2200 legal professionals and 3800 staff in over 50 offices and associated offices on six continents. The firm specialises in the sectors that move, build and power our connected world and the insurance that underpins it, namely: transport, infrastructure, energy, trade & commodities and insurance. With a strong focus on developed and emerging markets, the firm is one of the fastest growing law firms in the world with ambitious plans for further growth.
Bayer announced on Wednesday, June 24, it will pay up to $10.9 billion to settle a majority of approximately 125,000 claims that Monsanto's weed killer Roundup causes non-Hodgkin's lymphoma
UK Litigation, Mediation & Arbitration
To print this article, all you need is to be registered or login on Mondaq.com.

Bayer announced it will pay up to $10.9 billion to settle the majority of 125,000 claims that Monsanto's weedkiller Roundup causes non-Hodgkin's lymphoma.

Bayer announced on Wednesday, June 24, it will pay up to $10.9 billion to settle a majority of approximately 125,000 claims that Monsanto's weed killer Roundup causes non-Hodgkin's lymphoma. The settlement would end about 75% of the current Roundup litigation and cover approximately 95% of the Roundup cases pending trial. According to Bayer, the deal will include all litigation brought by plaintiff law firms leading the federal multidistrict litigation and California state court bellwether cases about the glyphosate-based herbicide.

Per Bayer, the settlement includes between $8.8 billion and $9.6 billion for resolving current Roundup litigation. This also includes plaintiffs who have hired attorneys but not yet filed claims in court and makes an allowance for the 25% of pending claims that are currently unresolved and still being negotiated. Bayer is also providing a separate payment of $1.25 billion for a class agreement that will address potential future cases brought by Roundup users who have not yet developed any illnesses. That class agreement will need the approval of U.S. District Judge Vince Chhabria of the Northern District of California, who is overseeing the federal MDL.

Bayer, which bought Monsanto in 2018, included in its announcement a statement from its CEO Werner Baumann, who said that the deal resolves most of the current litigation and establishes a clear way to manage future legal risks. The settlements contain no admission of liability or wrongdoing, according to the company.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More